Home › Employers › Cardiovascular Research Foundation
Cardiovascular Research Foundation: H-1B salaries and sponsorship
Cardiovascular Research Foundation filed 16 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 16. Median offered salary: $105,000.
Does Cardiovascular Research Foundation sponsor H-1B visas?
Cardiovascular Research Foundation filed 16 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 30, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Biostatistician | 5 | $100,000 |
| Medical Echo Core laboratory Analyst | 3 | $100,000 |
| Medical Director, Clinical Trials Center | 1 | $240,000 |
| ECHO Analyst | 1 | $70,000 |
| Associate Scientific Director, Data Coordinating Center | 1 | $250,000 |
| Clinical Data Manager | 1 | $110,000 |
| Veterinarian | 1 | $125,000 |
| Director, Translational Therapeutics | 1 | $480,000 |
| Senior Biostatistician | 1 | $119,000 |
| Clinical Operations Scientist | 1 | $68,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 2 | $85,000 |
| FY2024 | 2 | $180,000 |
| FY2025 | 6 | $100,000 |
| FY2026 | 6 | $115,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
- Medical Scientists, Except Epidemiologists6
- Statisticians6
- Data Scientists2
- Veterinarians1
- Epidemiologists1
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Clinical Operations Scientist | $68,000 Level I | New York, NY | Apr 30, 2026 | Jun 1, 2026 | Certified |
| Senior Biostatistician | $119,000 Level II | New York, NY | Mar 23, 2026 | Apr 6, 2026 | Certified |
| Biostatistician | $111,001 Level II | New York, NY | Feb 12, 2026 | Aug 7, 2026 | Certified, then withdrawn |
| Medical Echo Core laboratory Analyst | $100,000 Level II | New York, NY | Jul 31, 2025 | Sep 1, 2025 | Certified, then withdrawn |
| Director, Translational Therapeutics | $480,000 Level III | New York, NY | Jul 29, 2025 | Sep 1, 2025 | Certified |
| Medical Echo Core laboratory Analyst | $100,000 Level II | New York, NY | Feb 24, 2025 | Apr 1, 2025 | Certified |
| Biostatistician | $92,000 Level I | New York, NY | Oct 21, 2024 | Jan 29, 2025 | Certified |
| Associate Scientific Director, Data Coordinating Center | $250,000–$300,000 Level IV | New York, NY | Feb 27, 2024 | Mar 15, 2024 | Certified |
| Clinical Data Manager | $110,000 Level I | New York, NY | Feb 26, 2024 | Mar 15, 2024 | Certified |
| Veterinarian | $125,000 Level I | Orangeburg, NY | Feb 8, 2024 | Apr 1, 2024 | Certified, then withdrawn |
| Medical Echo Core laboratory Analyst | $125,000 Level II | New York, NY | Aug 24, 2023 | Sep 1, 2023 | Certified, then withdrawn |
| Biostatistician | $100,000 Level II | New York, NY | Jul 10, 2023 | Aug 7, 2023 | Certified |
| Medical Director, Clinical Trials Center | $240,000–$301,000 Level III | New York, NY | Jun 12, 2023 | Jul 1, 2023 | Certified, then withdrawn |
| Biostatistician | $100,000 Level II | New York, NY | Sep 22, 2022 | Jan 7, 2023 | Certified, then withdrawn |
| Biostatistician | $100,000 Level II | New York, NY | Sep 22, 2022 | Dec 1, 2022 | Certified, then withdrawn |
| ECHO Analyst | $70,000 Level II | New York, NY | Mar 19, 2020 | Jun 1, 2020 | Certified, then withdrawn |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).